Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 530 (RNA5SP530) is a member of the 5S rRNA pseudogene family, representing a non-functional (pseudogene) copy of the 5S ribosomal RNA gene. Pseudogenes are genomic DNA sequences derived from gene duplication or retrotransposition events that have lost their ability to encode functional RNA or protein due to mutations or lack of regulatory elements. RNA5SP530 does not encode a protein or a functional 5S ribosomal RNA and is not considered a therapeutic target, receptor, enzyme, transporter, or a molecule involved in signal transduction. Its biological significance, molecular classification, and disease involvement are minimal or unknown, and it is not tracked as a biomarker or safety concern in drug development.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 530 (RNA5SP530).